|1.||Januzzi, James L: 33 articles (08/2015 - 09/2006)|
|2.||Burnett, John C: 26 articles (12/2015 - 02/2002)|
|3.||Richards, A Mark: 22 articles (08/2015 - 01/2002)|
|4.||Mueller, Christian: 17 articles (04/2015 - 07/2007)|
|5.||Maisel, Alan: 15 articles (08/2014 - 09/2004)|
|6.||de Lemos, James A: 15 articles (12/2013 - 01/2003)|
|7.||Maisel, Alan S: 14 articles (06/2015 - 09/2005)|
|8.||Emdin, Michele: 12 articles (04/2015 - 09/2003)|
|9.||Vuolteenaho, Olli: 11 articles (09/2013 - 03/2004)|
|10.||Nicholls, M Gary: 11 articles (11/2008 - 01/2002)|
01/01/1996 - "Providing open access echocardiography, and/or targeting this resource to the most deserving cases by measuring plasma natriuretic peptides may help to optimize the use of this technique while improving the diagnosis of heart failure patients. "
01/01/2009 - "Over the past decade natriuretic peptides (NPs) became a very useful tool in the management of heart failure patients. "
03/01/2013 - "Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study."
10/01/2015 - "While the natriuretic peptides remain the gold standard heart failure biomarker, they are plagued by their non-specific nature; furthermore, the strategy of natriuretic peptide-guided care remains elusive. "
01/01/2011 - "Monitoring treatment efficacy and assessing outcome by serial measurements of natriuretic peptides in acute decompensated heart failure (ADHF) patients may help to improve outcome. "
01/01/2014 - "Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: insights from the meta-analysis of 1,389 patients from 20 trials."
09/01/2005 - "Few studies have compared the relative prognostic value of different natriuretic peptides after acute myocardial infarction (AMI). "
02/01/2014 - "Changes of natriuretic peptides concentration in early phase of acute myocardial infarction."
08/01/2013 - "Patients with increased blood concentrations of natriuretic peptides (NPs) have poor cardiovascular outcomes after myocardial infarction (MI). "
08/01/2013 - "Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG™."
|3.||Heart Diseases (Heart Disease)
03/14/2008 - "Natriuretic peptides (NPs) show promise in screening asymptomatic populations for structural heart disease, but little is known about their use in student athletes. "
01/01/2010 - "An astonishing amount of clinical studies have established cardiac natriuretic peptides and their molecular precursors as useful markers of heart disease. "
01/01/2008 - "Several studies have demonstrated that higher circulating levels of natriuretic peptides represent a strong independent risk factor for major cardiovascular complications and/or death, even in extra-cardiac diseases. "
11/01/2004 - "2. Recent studies have identified additional modes of action of the natriuretic peptides that may also confer cardioprotective benefits, especially in heart disease. "
12/19/2015 - "Using natriuretic peptides to detect cardiac diseases in horses."
|4.||Acute Coronary Syndrome
01/01/2004 - "Taken together, the acute actions of natriuretic peptides on the coronary vasculature and in myocardial ischaemia suggest a profile of activity that may be therapeutically beneficial in the management of patients with acute coronary syndromes."
08/01/2010 - "Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial."
05/01/2013 - "The potential role of natriuretic peptides in acute coronary syndrome stratification."
11/01/2012 - "B-type natriuretic peptides in acute coronary syndromes: implications in an aging population."
08/01/2010 - "Elevated natriuretic peptides (NPs) are associated with an increased cardiovascular risk following acute coronary syndromes (ACSs). "
01/01/2010 - "Natriuretic peptides (NPs) have potent antiproliferative and antimigratory effects on vascular smooth-muscle cells (VSMCs) and, in atherosclerosis, participate in vascular remodeling, in which the expression of NP clearance receptors (NPR-Cs) is upregulated both in endothelium and in VSMCs. "
09/01/2004 - "[Natriuretic peptides and atherosclerosis]."
01/01/2004 - "In recent years however a new pharmacological approach has evolved as a result of (i) the dissociation of endothelial dysfunction and vascular pathology from increased blood pressure; (ii) the recognition that endothelial dysfunction regards not only the vascular reactivity, but also promotes atherosclerosis and thrombosis; and (iii) an improved understanding of the complexity of local-tissue renin angiotensin system and of the vasodilatory and cytoprotective role of natriuretic peptides. "
07/01/2014 - "Moreover, the natriuretic peptides have been implicated in the protection against atherosclerosis, thrombosis, and myocardial ischaemia. "
01/01/2008 - "Brain natriuretic peptides as biomarkers for atherosclerosis."
|1.||Biological Markers (Surrogate Marker)
|2.||pro-brain natriuretic peptide (1-76)
|3.||Brain Natriuretic Peptide (Natrecor)
|5.||Atrial Natriuretic Factor (ANF)
|6.||Neprilysin (Neutral Endopeptidase)
|7.||atrial natriuretic factor receptor A
|1.||Renal Dialysis (Hemodialysis)
|2.||Cardiac Resynchronization Therapy
|5.||Surgical Instruments (Clip)